New  research conducted by biologists at Texas  A&M   University   suggests that sertraline (see structure below, ZOLOFT®), one of the most widely prescribed antidepressants in the world, also  packs a potential preventative bonus  potent mechanisms capable of inhibiting  deadly fungal infections. 
C.  neoformans is  a potentially dangerous fungal pathogen found in many soils throughout the world  that may cause systemic infections, particularly involving the central nervous  system. In most cases, the microscopic, airborne fungal cells of C. neoformans cause asymptomatic colonization in  the lungs. However, Lin says the fungus is particularly aggressive in people  with weakened immune systems and can spread to other parts of the body, such as  the brain and spinal cord, resulting in cryptococcal  meningitis  a  condition that, in absence of treatment, is fatal. 
Investigation  of sertraline in a mouse model of systemic cryptococcosis revealed that it combats infection similar to  fluconazole, an antifungal drug used commonly since  the early 1990s. Moreover, a drug combination of sertraline and fluconazole was  found to work more efficiently than either drug alone.
Lin  says that even though the infection ultimately proved fatal in the mice study,  sertraline as a cryptoccol  treatment still holds promise. Because sertraline  reduced the overall fungal burden within the mice and also possesses the  desirable ability to cross the blood-brain barrier as an antidepressant, there  is still hope it can be altered to serve as a viable treatment  option.....
